On Sep, 2019, Xantho Bio. successfully obtained a permit from the US FDA to carry out a multi-tasked, phase I/IIa trial for a new botanic drug with dermotology use.
(+886) 2-2655-7790・(+886) 2-2655-8633 ext.3121
Rm. ER12A, 17F.-1, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)